Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesJan 15, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 11, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 10, 2019View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesJan 9, 2019View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventJan 8, 2019View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesJan 2, 2019View HTMLDownload DOCDownload PDF

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information